New results from a study of a drug called Gazyva (obinutuzumab) showed that it significantly reduced disease activity in adults with systemic lupus erythematosus (SLE). The drug was developed by ...

The American College of Rheumatology (ACR) released new guidelines for the treatment and management of systemic lupus erythematosus (SLE), the most common form of lupus. These guidelines replace the ...

Shares of micro-cap playable media company Super League Enterprise Inc (NASDAQ:SLE) are soaring in extended trading on Monday after the company announced an investment from Evo Fund. SLE stock is ...

Prolonged remission was observed in 72% of patients with systemic lupus erythematosus (SLE) who were treated with a consistent 200 mg daily dose of hydroxychloroquine. The mean weight-adjusted ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Black patients, particularly women, had the highest ...

Bristol Myers Squibb has linked its CD19-directed CAR-T cell therapy to sustained clinical responses in people with systemic lupus erythematosus (SLE), providing further evidence that the emerging ...

Petrolheads often spend hours on end poring over the latest models from their favorite manufacturers. As much fun as it is salivating over their specs and considering the virtues of different paint ...

Please provide your email address to receive an email when new articles are posted on . The FDA has cleared an investigational new drug application for Eque-cel in patients with SLE and lupus ...

In 1978, a team of Harvard Medical School researchers examined whether people with lupus responded to the influenza vaccine differently from the way a group of “normal” control subjects did. They ...

VIENNA — Glucocorticoid discontinuation is possible without increasing flare risk, if tapered slowly and carefully, in patients with systemic lupus erythematosus (SLE) in stable remission. In ...